Interleukin-2, interferon-alpha, 5-fluorouracil, and vinblastine in the treatment of metastatic renal cell carcinoma: a prospective phase II study: the experience of Rambam and Lin Medical Centers 1996-2000. [electronic resource]
Producer: 20021029Description: 1644-9 p. digitalISSN:- 0008-543X
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carcinoma, Renal Cell -- drug therapy
- Disease-Free Survival
- Female
- Fluorouracil -- administration & dosage
- Humans
- Injections, Intravenous
- Injections, Subcutaneous
- Interferon-alpha -- administration & dosage
- Interleukin-2 -- administration & dosage
- Kidney Neoplasms -- drug therapy
- Male
- Middle Aged
- Nephrectomy
- Prospective Studies
- Treatment Outcome
- Vinblastine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.